Vinod R Purayath, James K Kai, Jayavel Pachamuthu, Jarrett Jun Liang, George Matamis: Semiconductor device with copper interconnects separated by air gaps. Sandisk Technologies, The Marbury Law Group PLLC, May 12, 2015: US09030016

A semiconductor device including a plurality of copper interconnects. At least a first portion of the plurality of copper interconnects has a meniscus in a top surface. The semiconductor device also includes a plurality of air gaps, wherein each air gap of the plurality of air gaps is located betwee ...

Josef Bencsik, James F Blake, James M Graham, Martin F Hentemann, Nicholas C Kallan, Ian S Mitchell, Stephen T Schlachter, Keith L Spencer, Dengming Xiao, Rui Xu, Mike Welch, Jun Liang, Brian S Safina: Pyrimidyl cyclopentanes as AKT protein kinase inhibitors. ARRAY BIOPHARMA, Genentech, Viksnins Harris & Padys PLLP, August 9, 2016: US09409886

The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for ...

Toby Jonathan Blench, Charles Ellwood, Simon Charles Goodacre, Yingjie Lai, Jun Liang, Calum Macleod, Steven R Magnuson, Vickie H Tsui, Karen Williams, Birong Zhang: Azabenzothiazole compounds, compositions and methods of use. F Hoffmann La Roche, Tamara Kale, Genentech, April 15, 2014: US08697708

Provided are compounds of Formula I, stereoisomers, tautomers, solvates, prodrugs and pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R4 and R5 are defined herein, a pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant ...

Bing Yan Zhu, Michael Siu, Steven R Magnuson, Richard Pastor, He Haiying, Xiao Yisong, Zheng Jifu, Xu Xing, Zhao Junping, Christopher Hurley, Jun Liang, Wendy Liu, Joseph P Lyssikatos: Triazolopyridine JAK inhibitor compounds and methods. Genentech, Tamara A Kale, September 6, 2016: US09434732

A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined herein, are useful as JAK kinase inhibitors. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable car ...

Brian K Albrecht, Steven F Bellon, Victor S Gehling, Jean Christophe Harmange, Kwong Wah Lai, Jun Liang, Peter Dragovich, Daniel F Ortwine, Sharada Labadie, Birong Zhang, James Richard Kiefer: Pyrazolo compounds and uses thereof. Genentech, CONSTELLATION PHARMACEUTICALS, Viksnins Harris Padys Malen, July 31, 2018: US10035801

Provided are compounds useful as inhibitors of one or more histone demethylases, such as KDM5. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using the present composition in the treatment of various disorders.

Sharada Labadie, Jun Liang, Daniel Fred Ortwine, Xiaojing Wang, Birong Zhang, Nicholas D Smith, Steven P Govek, Mehmet Kahraman, Andiliy G Lai, Johnny Y Nagasawa, Simon Charles Goodacre, Nicholas Charles Ray: Heterocyclic estrogen receptor modulators and uses thereof. Genentech, Kevin M Clark, August 21, 2018: US10053451

Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating ...

Anna Leivers, Josef R Bencsik, James F Blake, Martin F Hentemann, Nicholas C Kallan, Jun Liang, Ian S Mitchell, Stephen T Schlachter, Eli M Wallace, Rui Xu, Tony P Tang: 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors. Genentech, ARRAY BIOPHARMA, Viksnins Harris & Padys PLLP, May 3, 2016: US09328091

Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pat ...

Che Yu Chou, Qun Huang, Tai Shan Zhu, Wen Chih Lan, Tao Jiang, Hai Qian Ge, Jun Liang Zhang, Wei Wei Yu, Hua Yong Wang, Ji Bing Guo, Zhou Chen, Zhi Jun Shi: Electronic device. Fu Tai Hua, Hon Hai Precision, Novak Druce Connolly Bove Quigg, December 9, 2014: US08908370

An electronic device includes a body, a cover coupled to the body, and a sliding mechanism. The sliding mechanism includes a rotating component, a first locking component, and a second locking component. When the second locking component moves to a locked position, the second locking component engag ...


Ya Chih Hsiao, Jun Liang Lu: Electronic device and method for adjusting setting for projecting screen by re-calculating ambient contrast ratio according to variation of ambient light. Acer Incorporated, Jianq Chyun IP Office, September 19, 2017: US09769441

An electronic device including a projection unit, an ambient light sensor and a processing unit is provided. The projection unit has a projection lens fixed on a side surface of the electronic device. The ambient light sensor is fixed on the side surface of the electronic device. The processing unit ...